Cargando…

Correction: Molecular response prediction in CML: novel ideas?

Detalles Bibliográficos
Autores principales:	Wolf, Dominik, Sopper, Sieghart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254682/ https://www.ncbi.nlm.nih.gov/pubmed/30533202 http://dx.doi.org/10.18632/oncotarget.26360

Ejemplares similares

Molecular response prediction in CML: novel ideas?
por: Wolf, Dominik, et al.
Publicado: (2017)

Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype
por: Boesch, Maximilian, et al.
Publicado: (2016)

Modulation of Immune Cell Functions by the E3 Ligase Cbl-b
por: Lutz-Nicoladoni, Christina, et al.
Publicado: (2015)

NK Cells in Myeloproliferative Neoplasms (MPN)
por: Naismith, Erin, et al.
Publicado: (2021)

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
por: Hehlmann, Rüdiger, et al.
Publicado: (2020)

Correction to: ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
por: Zu, Bailing, et al.
Publicado: (2022)

Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
por: Finotello, Francesca, et al.
Publicado: (2019)

Correction: ATRA-Induced Cellular Differentiation and CD38 Expression Inhibits Acquisition of BCR-ABL Mutations for CML Acquired Resistance
Publicado: (2015)

Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells
por: Yang, Hao, et al.
Publicado: (2020)

Correction to: From idea to systems solution: enhancing access to primary care in Malawi
por: van Niekerk, L., et al.
Publicado: (2023)

MicroRNA signature refine response prediction in CML
por: Alves, Raquel, et al.
Publicado: (2019)

Noncytolytic CD8(+) Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques
por: Javed, Aneela, et al.
Publicado: (2015)

Correction to: The biological Maxwell's demons: exploring ideas about the information processing in biological systems
por: Mizraji, Eduardo
Publicado: (2021)

The Role of Early Molecular Response in the Management of Chronic Phase CML
por: Harrington, Patrick, et al.
Publicado: (2017)

In vitro SIV replication kinetics correlate with vaccine induced cellular immune responses and predict post-challenge outcome in immunized rhesus macaques
por: Ochieng, Washingtone, et al.
Publicado: (2006)

High prevalence of side population in human cancer cell lines
por: Boesch, Maximilian, et al.
Publicado: (2016)

Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
por: Eller, Kathrin, et al.
Publicado: (2011)

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib
por: Stella, Stefania, et al.
Publicado: (2019)

Author Correction: Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model
por: Kazemi‑Sefat, Golnaz Ensieh, et al.
Publicado: (2023)

Correction to: Ideas, actors and institutions: lessons from South Australian Health in All Policies on what encourages other sectors’ involvement
por: Baum, Fran, et al.
Publicado: (2017)

Correction: Correction: Physiological and Molecular Responses to Excess Boron in Citrus macrophylla W
Publicado: (2015)

Effect of Cellular Quiescence on the Success of Targeted CML Therapy
por: Komarova, Natalia L., et al.
Publicado: (2007)

Evaluation of Vav3.1 as prognostic marker in endometrial cancer
por: Boesch, Maximilian, et al.
Publicado: (2018)

The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
por: Boesch, Maximilian, et al.
Publicado: (2014)

High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome
por: Wolf, Dominik, et al.
Publicado: (2019)

Correction: In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer
por: Miyazaki, Ryohei, et al.
Publicado: (2016)

Correction: Predicting Tumor Responses to Gefitinib and Erlotinib
Publicado: (2012)

Stable multi-infection of splenocytes during SIV infection - the basis for continuous recombination
por: Schultz, Anke, et al.
Publicado: (2012)

Increased BST2 expression during simian immunodeficiency virus infection is not a determinant of disease progression in rhesus monkeys
por: Mussil, Bianka, et al.
Publicado: (2015)

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
por: Valent, Peter, et al.
Publicado: (2019)

Quantitative prediction of long-term molecular response in TKI-treated CML – Lessons from an imatinib versus dasatinib comparison
por: Glauche, Ingmar, et al.
Publicado: (2018)

Cytogenetic study in CML
por: Subramanian, P.G.
Publicado: (2012)

CML: Evolution and design
por: Murray-Rust, Peter, et al.
Publicado: (2011)

Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
por: Carter, Philip, et al.
Publicado: (2018)

Identification of molecular sub-networks associated with cell survival in a chronically SIVmac-infected human CD4+ T cell line
por: He, Feng Q, et al.
Publicado: (2014)

Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys
por: Mußil, Bianka, et al.
Publicado: (2011)

Reply: The long-term response to imatinib treatment of CML
por: Michor, F
Publicado: (2007)

Correction: Physiological and Molecular Responses to Excess Boron in Citrus macrophylla W
por: Martínez-Cuenca, Mary-Rus, et al.
Publicado: (2015)

Correction: Differential Responses to Wnt and PCP Disruption Predict Expression and Developmental Function of Conserved and Novel Genes in a Cnidarian
Publicado: (2014)

The Combination of Interferon-Alpha and Ponatinib Enables Faster and Deeper Molecular Responses in Patient with De Novo Blast Crisis of CML: Interferon-Alpha May Return as a CML Treatment
por: Hayashi, Kunio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_biduh6v768157joq3kek1e1qhj